Evidence map›Paper›PMID 32486126›Full record

ArticleCells2020

Human Liver-Derived Extracellular Matrix for the Culture of Distinct Human Primary Liver Cells.

Niki Alevra Sarika, Valéry L Payen, Maximilien Fléron, Joachim Ravau, Davide Brusa, Mustapha Najimi, Edwin De Pauw, Gauthier Eppe, Gabriel Mazzucchelli, Etienne M Sokal and 2 more

Open access · goldAbstract read
In one paragraph

Article in Cells, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Niki Alevra SarikaLaboratory of Pediatric Hepatology and Cell Therapy (PEDI), Institute of Experimental and Clinical Research (IREC), Université catholique de Louvain (UCLouvain), Avenue Mounier 52 Box B1.52.03, 1200 Brussels, Belgium.
Valéry L PayenLaboratory of Pediatric Hepatology and Cell Therapy (PEDI), Institute of Experimental and Clinical Research (IREC), Université catholique de Louvain (UCLouvain), Avenue Mounier 52 Box B1.52.03, 1200 Brussels, Belgium.
Maximilien FléronGIGA-Proteomics Facility, University of Liège (ULiège), Allée du six août 11, 4000 Liège, Belgium.
Joachim RavauLaboratory of Pediatric Hepatology and Cell Therapy (PEDI), Institute of Experimental and Clinical Research (IREC), Université catholique de Louvain (UCLouvain), Avenue Mounier 52 Box B1.52.03, 1200 Brussels, Belgium.
Davide BrusaFlow Cytometry Technological Platform, Institute of Experimental and Clinical Research (IREC), Université catholique de Louvain (UCLouvain), Avenue Hippocrate 55 Box B1.55.20, 1200 Brussels, Belgium.
Mustapha NajimiLaboratory of Pediatric Hepatology and Cell Therapy (PEDI), Institute of Experimental and Clinical Research (IREC), Université catholique de Louvain (UCLouvain), Avenue Mounier 52 Box B1.52.03, 1200 Brussels, Belgium.
Edwin De PauwMass Spectrometry Laboratory (MSLab), MolSys Research Unit, University of Liège (ULiège), Allée du six août 11, 4000 Liège, Belgium.
Gauthier EppeMass Spectrometry Laboratory (MSLab), MolSys Research Unit, University of Liège (ULiège), Allée du six août 11, 4000 Liège, Belgium.
Gabriel MazzucchelliMass Spectrometry Laboratory (MSLab), MolSys Research Unit, University of Liège (ULiège), Allée du six août 11, 4000 Liège, Belgium.
Etienne M SokalLaboratory of Pediatric Hepatology and Cell Therapy (PEDI), Institute of Experimental and Clinical Research (IREC), Université catholique de Louvain (UCLouvain), Avenue Mounier 52 Box B1.52.03, 1200 Brussels, Belgium.
Anne des RieuxLaboratory of Advanced Drug Delivery and Biomaterials (ADDB), Louvain Drug Research Institute (LDRI), Université catholique de Louvain (UCLouvain), Avenue Mounier 73 Box B1.73.12, 1200 Brussels, Belgium.
Adil El TaghdouiniLaboratory of Pediatric Hepatology and Cell Therapy (PEDI), Institute of Experimental and Clinical Research (IREC), Université catholique de Louvain (UCLouvain), Avenue Mounier 52 Box B1.52.03, 1200 Brussels, Belgium.
UCLouvain · BEUniversity of Liège · BE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The lack of robust methods to preserve, purify and in vitro maintain the phenotype of the human liver's highly specialized parenchymal and non-parenchymal cell types importantly hampers their exploitation for the development of research and clinical applications. There is in this regard a growing interest in the use of tissue-specific extracellular matrix (ECM) to provide cells with an in vitro environment that more closely resembles that of the native tissue. In the present study, we have developed a method that allows for the isolation and downstream application of the human liver's main cell types from cryopreserved material. We also isolated and solubilized human liver ECM (HL-ECM), analyzed its peptidomic and proteomic composition by mass spectrometry and evaluated its interest for the culture of distinct primary human liver cells. Our analysis of the HL-ECM revealed proteomic diversity, type 1 collagen abundance and partial loss of integrity following solubilization. Solubilized HL-ECM was evaluated either as a coating or as a medium supplement for the culture of human primary hepatocytes, hepatic stellate cells and liver sinusoidal endothelial cells. Whereas the solubilized HL-ECM was suitable for cell culture, its impact on the phenotype and/or functionality of the human liver cells was limited. Our study provides a first detailed characterization of solubilized HL-ECM and a first report of its influence on the culture of distinct human primary liver cells.

Indexed as

Cell Culture TechniquesCells, CulturedCryopreservationExtracellular MatrixHumansLiverPeptidesProteomicsSolubilityPeptidesdecellularizationextracellular matrixliverprimary cellsproteomics

Identifiers

PMID32486126
PMCPMC7349413
OpenAlexW3029563942

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.